nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—Abdominal pain upper—Telbivudine—hepatitis B	0.00323	0.00367	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00318	0.00362	CcSEcCtD
Citalopram—Cramp muscle—Telbivudine—hepatitis B	0.00318	0.00362	CcSEcCtD
Citalopram—Haematuria—Entecavir—hepatitis B	0.00316	0.00359	CcSEcCtD
Citalopram—Nasopharyngitis—Telbivudine—hepatitis B	0.00316	0.00359	CcSEcCtD
Citalopram—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00315	0.00358	CcSEcCtD
Citalopram—Hepatobiliary disease—Entecavir—hepatitis B	0.00314	0.00356	CcSEcCtD
Citalopram—Gastritis—Telbivudine—hepatitis B	0.00313	0.00355	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00312	0.00354	CcSEcCtD
Citalopram—Muscular weakness—Telbivudine—hepatitis B	0.00312	0.00354	CcSEcCtD
Citalopram—Rhabdomyolysis—Lamivudine—hepatitis B	0.0031	0.00352	CcSEcCtD
Citalopram—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00309	0.0035	CcSEcCtD
Citalopram—Abdominal distension—Telbivudine—hepatitis B	0.00308	0.00349	CcSEcCtD
Citalopram—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00306	0.00348	CcSEcCtD
Citalopram—Influenza—Telbivudine—hepatitis B	0.00306	0.00347	CcSEcCtD
Citalopram—Bone disorder—Lamivudine—hepatitis B	0.00304	0.00345	CcSEcCtD
Citalopram—Rectal haemorrhage—Lamivudine—hepatitis B	0.00304	0.00345	CcSEcCtD
Citalopram—Viral infection—Lamivudine—hepatitis B	0.00304	0.00345	CcSEcCtD
Citalopram—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00304	0.00345	CcSEcCtD
Citalopram—Hepatitis—Entecavir—hepatitis B	0.00298	0.00338	CcSEcCtD
Citalopram—Drug interaction—Lamivudine—hepatitis B	0.00296	0.00336	CcSEcCtD
Citalopram—Oedema peripheral—Entecavir—hepatitis B	0.00293	0.00333	CcSEcCtD
Citalopram—Abdominal discomfort—Telbivudine—hepatitis B	0.00293	0.00333	CcSEcCtD
Citalopram—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00291	0.0033	CcSEcCtD
Citalopram—Hypercholesterolaemia—Lamivudine—hepatitis B	0.0029	0.0033	CcSEcCtD
Citalopram—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00288	0.00327	CcSEcCtD
Citalopram—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00287	0.00326	CcSEcCtD
Citalopram—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00285	0.00324	CcSEcCtD
Citalopram—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00285	0.00323	CcSEcCtD
Citalopram—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00284	0.00322	CcSEcCtD
Citalopram—Muscle twitching—Lamivudine—hepatitis B	0.0028	0.00317	CcSEcCtD
Citalopram—Musculoskeletal pain—Lamivudine—hepatitis B	0.00278	0.00315	CcSEcCtD
Citalopram—Eructation—Lamivudine—hepatitis B	0.0027	0.00306	CcSEcCtD
Citalopram—Immune system disorder—Entecavir—hepatitis B	0.00269	0.00305	CcSEcCtD
Citalopram—Neuropathy peripheral—Telbivudine—hepatitis B	0.00267	0.00303	CcSEcCtD
Citalopram—Wheezing—Lamivudine—hepatitis B	0.00267	0.00303	CcSEcCtD
Citalopram—Alopecia—Entecavir—hepatitis B	0.00263	0.00299	CcSEcCtD
Citalopram—Mental disorder—Entecavir—hepatitis B	0.00261	0.00296	CcSEcCtD
Citalopram—Malnutrition—Entecavir—hepatitis B	0.00259	0.00294	CcSEcCtD
Citalopram—Aplastic anaemia—Lamivudine—hepatitis B	0.00258	0.00293	CcSEcCtD
Citalopram—Neuropathy—Lamivudine—hepatitis B	0.00258	0.00293	CcSEcCtD
Citalopram—Photophobia—Lamivudine—hepatitis B	0.00258	0.00293	CcSEcCtD
Citalopram—Hepatobiliary disease—Telbivudine—hepatitis B	0.00258	0.00293	CcSEcCtD
Citalopram—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00253	0.00287	CcSEcCtD
Citalopram—SLC6A4—blood plasma—hepatitis B	0.00252	0.116	CbGeAlD
Citalopram—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00249	0.00283	CcSEcCtD
Citalopram—Mouth ulceration—Lamivudine—hepatitis B	0.00248	0.00282	CcSEcCtD
Citalopram—Urine output increased—Lamivudine—hepatitis B	0.00248	0.00282	CcSEcCtD
Citalopram—Gynaecomastia—Lamivudine—hepatitis B	0.00246	0.00279	CcSEcCtD
Citalopram—Back pain—Adefovir Dipivoxil—hepatitis B	0.00245	0.00278	CcSEcCtD
Citalopram—Hepatitis—Telbivudine—hepatitis B	0.00245	0.00278	CcSEcCtD
Citalopram—Hypoaesthesia—Telbivudine—hepatitis B	0.00243	0.00276	CcSEcCtD
Citalopram—Pharyngitis—Telbivudine—hepatitis B	0.00243	0.00276	CcSEcCtD
Citalopram—Connective tissue disorder—Telbivudine—hepatitis B	0.0024	0.00273	CcSEcCtD
Citalopram—Sepsis—Lamivudine—hepatitis B	0.00238	0.0027	CcSEcCtD
Citalopram—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00234	0.00265	CcSEcCtD
Citalopram—Lymphadenopathy—Lamivudine—hepatitis B	0.00234	0.00265	CcSEcCtD
Citalopram—Leukopenia—Entecavir—hepatitis B	0.00232	0.00263	CcSEcCtD
Citalopram—Phlebitis—Lamivudine—hepatitis B	0.00231	0.00263	CcSEcCtD
Citalopram—Sleep disorder—Lamivudine—hepatitis B	0.0023	0.00261	CcSEcCtD
Citalopram—Polyuria—Lamivudine—hepatitis B	0.00227	0.00258	CcSEcCtD
Citalopram—Gastroenteritis—Lamivudine—hepatitis B	0.00225	0.00255	CcSEcCtD
Citalopram—Deafness—Lamivudine—hepatitis B	0.00223	0.00253	CcSEcCtD
Citalopram—Cough—Adefovir Dipivoxil—hepatitis B	0.00221	0.00251	CcSEcCtD
Citalopram—Mediastinal disorder—Telbivudine—hepatitis B	0.0022	0.0025	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00219	0.00249	CcSEcCtD
Citalopram—Injury—Lamivudine—hepatitis B	0.00217	0.00246	CcSEcCtD
Citalopram—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00215	0.00244	CcSEcCtD
Citalopram—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00215	0.00244	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00214	0.00243	CcSEcCtD
Citalopram—Malnutrition—Telbivudine—hepatitis B	0.00213	0.00242	CcSEcCtD
Citalopram—Anaphylactic shock—Entecavir—hepatitis B	0.00212	0.0024	CcSEcCtD
Citalopram—Infection—Entecavir—hepatitis B	0.0021	0.00239	CcSEcCtD
Citalopram—Thirst—Lamivudine—hepatitis B	0.00209	0.00238	CcSEcCtD
Citalopram—CYP2C19—blood plasma—hepatitis B	0.00209	0.0958	CbGeAlD
Citalopram—Dysgeusia—Telbivudine—hepatitis B	0.00209	0.00237	CcSEcCtD
Citalopram—Nervous system disorder—Entecavir—hepatitis B	0.00207	0.00236	CcSEcCtD
Citalopram—Back pain—Telbivudine—hepatitis B	0.00206	0.00234	CcSEcCtD
Citalopram—Skin disorder—Entecavir—hepatitis B	0.00205	0.00233	CcSEcCtD
Citalopram—Muscle spasms—Telbivudine—hepatitis B	0.00205	0.00232	CcSEcCtD
Citalopram—Hypoglycaemia—Lamivudine—hepatitis B	0.00204	0.00232	CcSEcCtD
Citalopram—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00202	0.0023	CcSEcCtD
Citalopram—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00202	0.00229	CcSEcCtD
Citalopram—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.002	0.00228	CcSEcCtD
Citalopram—Ill-defined disorder—Telbivudine—hepatitis B	0.00198	0.00224	CcSEcCtD
Citalopram—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00197	0.00223	CcSEcCtD
Citalopram—Migraine—Lamivudine—hepatitis B	0.00196	0.00223	CcSEcCtD
Citalopram—Affect lability—Lamivudine—hepatitis B	0.00196	0.00223	CcSEcCtD
Citalopram—Malaise—Telbivudine—hepatitis B	0.00192	0.00218	CcSEcCtD
Citalopram—Insomnia—Entecavir—hepatitis B	0.00191	0.00217	CcSEcCtD
Citalopram—Mood swings—Lamivudine—hepatitis B	0.00189	0.00214	CcSEcCtD
Citalopram—Somnolence—Entecavir—hepatitis B	0.00188	0.00214	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00188	0.00214	CcSEcCtD
Citalopram—Dyspepsia—Entecavir—hepatitis B	0.00186	0.00211	CcSEcCtD
Citalopram—Cough—Telbivudine—hepatitis B	0.00186	0.00211	CcSEcCtD
Citalopram—Dehydration—Lamivudine—hepatitis B	0.00185	0.0021	CcSEcCtD
Citalopram—Liver function test abnormal—Lamivudine—hepatitis B	0.00184	0.00209	CcSEcCtD
Citalopram—Gastrointestinal disorder—Entecavir—hepatitis B	0.00183	0.00207	CcSEcCtD
Citalopram—Fatigue—Entecavir—hepatitis B	0.00182	0.00207	CcSEcCtD
Citalopram—Abdominal pain upper—Lamivudine—hepatitis B	0.00182	0.00207	CcSEcCtD
Citalopram—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00182	0.00206	CcSEcCtD
Citalopram—Chest pain—Telbivudine—hepatitis B	0.00181	0.00206	CcSEcCtD
Citalopram—Arthralgia—Telbivudine—hepatitis B	0.00181	0.00206	CcSEcCtD
Citalopram—Myalgia—Telbivudine—hepatitis B	0.00181	0.00206	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0018	0.00204	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00179	0.00204	CcSEcCtD
Citalopram—Cramp muscle—Lamivudine—hepatitis B	0.00179	0.00204	CcSEcCtD
Citalopram—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00179	0.00204	CcSEcCtD
Citalopram—Discomfort—Telbivudine—hepatitis B	0.00179	0.00203	CcSEcCtD
Citalopram—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00178	0.00202	CcSEcCtD
Citalopram—Nasopharyngitis—Lamivudine—hepatitis B	0.00178	0.00202	CcSEcCtD
Citalopram—Muscular weakness—Lamivudine—hepatitis B	0.00176	0.002	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00176	0.002	CcSEcCtD
Citalopram—Abdominal distension—Lamivudine—hepatitis B	0.00173	0.00197	CcSEcCtD
Citalopram—Gastrointestinal pain—Entecavir—hepatitis B	0.00173	0.00196	CcSEcCtD
Citalopram—Dysphagia—Lamivudine—hepatitis B	0.00172	0.00196	CcSEcCtD
Citalopram—Influenza—Lamivudine—hepatitis B	0.00172	0.00196	CcSEcCtD
Citalopram—CYP1A2—blood plasma—hepatitis B	0.00171	0.0783	CbGeAlD
Citalopram—Nervous system disorder—Telbivudine—hepatitis B	0.0017	0.00194	CcSEcCtD
Citalopram—Thrombocytopenia—Telbivudine—hepatitis B	0.0017	0.00193	CcSEcCtD
Citalopram—Pancreatitis—Lamivudine—hepatitis B	0.00169	0.00192	CcSEcCtD
Citalopram—Skin disorder—Telbivudine—hepatitis B	0.00169	0.00192	CcSEcCtD
Citalopram—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00169	0.00192	CcSEcCtD
Citalopram—Sweating increased—Lamivudine—hepatitis B	0.00168	0.0019	CcSEcCtD
Citalopram—Abdominal pain—Entecavir—hepatitis B	0.00167	0.0019	CcSEcCtD
Citalopram—Body temperature increased—Entecavir—hepatitis B	0.00167	0.0019	CcSEcCtD
Citalopram—Bronchitis—Lamivudine—hepatitis B	0.00166	0.00188	CcSEcCtD
Citalopram—Abdominal discomfort—Lamivudine—hepatitis B	0.00165	0.00187	CcSEcCtD
Citalopram—Pancytopenia—Lamivudine—hepatitis B	0.00164	0.00186	CcSEcCtD
Citalopram—CYP2B6—blood plasma—hepatitis B	0.00163	0.075	CbGeAlD
Citalopram—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00163	0.00185	CcSEcCtD
Citalopram—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00163	0.00185	CcSEcCtD
Citalopram—Dysuria—Lamivudine—hepatitis B	0.00161	0.00183	CcSEcCtD
Citalopram—Pollakiuria—Lamivudine—hepatitis B	0.00159	0.00181	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00158	0.0018	CcSEcCtD
Citalopram—Insomnia—Telbivudine—hepatitis B	0.00157	0.00178	CcSEcCtD
Citalopram—Paraesthesia—Telbivudine—hepatitis B	0.00156	0.00177	CcSEcCtD
Citalopram—Hyperglycaemia—Lamivudine—hepatitis B	0.00155	0.00176	CcSEcCtD
Citalopram—CYP2E1—blood plasma—hepatitis B	0.00153	0.0704	CbGeAlD
Citalopram—Depression—Lamivudine—hepatitis B	0.00153	0.00174	CcSEcCtD
Citalopram—Dyspepsia—Telbivudine—hepatitis B	0.00153	0.00174	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00152	0.00173	CcSEcCtD
Citalopram—Asthenia—Entecavir—hepatitis B	0.00152	0.00172	CcSEcCtD
Citalopram—Neuropathy peripheral—Lamivudine—hepatitis B	0.00151	0.00171	CcSEcCtD
Citalopram—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0015	0.0017	CcSEcCtD
Citalopram—Fatigue—Telbivudine—hepatitis B	0.0015	0.0017	CcSEcCtD
Citalopram—Stomatitis—Lamivudine—hepatitis B	0.0015	0.0017	CcSEcCtD
Citalopram—Jaundice—Lamivudine—hepatitis B	0.0015	0.0017	CcSEcCtD
Citalopram—Pain—Telbivudine—hepatitis B	0.00149	0.00169	CcSEcCtD
Citalopram—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00148	0.00168	CcSEcCtD
Citalopram—Sweating—Lamivudine—hepatitis B	0.00147	0.00167	CcSEcCtD
Citalopram—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00146	0.00166	CcSEcCtD
Citalopram—Hepatobiliary disease—Lamivudine—hepatitis B	0.00145	0.00165	CcSEcCtD
Citalopram—Epistaxis—Lamivudine—hepatitis B	0.00145	0.00164	CcSEcCtD
Citalopram—Diarrhoea—Entecavir—hepatitis B	0.00145	0.00164	CcSEcCtD
Citalopram—Sinusitis—Lamivudine—hepatitis B	0.00144	0.00164	CcSEcCtD
Citalopram—Agranulocytosis—Lamivudine—hepatitis B	0.00143	0.00163	CcSEcCtD
Citalopram—Feeling abnormal—Telbivudine—hepatitis B	0.00143	0.00163	CcSEcCtD
Citalopram—Gastrointestinal pain—Telbivudine—hepatitis B	0.00142	0.00161	CcSEcCtD
Citalopram—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00141	0.0016	CcSEcCtD
Citalopram—Dizziness—Entecavir—hepatitis B	0.0014	0.00159	CcSEcCtD
Citalopram—Rhinitis—Lamivudine—hepatitis B	0.00138	0.00157	CcSEcCtD
Citalopram—Hepatitis—Lamivudine—hepatitis B	0.00138	0.00157	CcSEcCtD
Citalopram—Abdominal pain—Telbivudine—hepatitis B	0.00137	0.00156	CcSEcCtD
Citalopram—Body temperature increased—Telbivudine—hepatitis B	0.00137	0.00156	CcSEcCtD
Citalopram—Hypoaesthesia—Lamivudine—hepatitis B	0.00137	0.00156	CcSEcCtD
Citalopram—Pharyngitis—Lamivudine—hepatitis B	0.00137	0.00155	CcSEcCtD
Citalopram—Connective tissue disorder—Lamivudine—hepatitis B	0.00135	0.00154	CcSEcCtD
Citalopram—Vomiting—Entecavir—hepatitis B	0.00135	0.00153	CcSEcCtD
Citalopram—Rash—Entecavir—hepatitis B	0.00133	0.00151	CcSEcCtD
Citalopram—Dermatitis—Entecavir—hepatitis B	0.00133	0.00151	CcSEcCtD
Citalopram—Headache—Entecavir—hepatitis B	0.00133	0.0015	CcSEcCtD
Citalopram—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00131	0.00149	CcSEcCtD
Citalopram—Erythema multiforme—Lamivudine—hepatitis B	0.0013	0.00148	CcSEcCtD
Citalopram—Rash—Adefovir Dipivoxil—hepatitis B	0.0013	0.00148	CcSEcCtD
Citalopram—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0013	0.00148	CcSEcCtD
Citalopram—Headache—Adefovir Dipivoxil—hepatitis B	0.00129	0.00147	CcSEcCtD
Citalopram—Nausea—Entecavir—hepatitis B	0.00126	0.00143	CcSEcCtD
Citalopram—Asthenia—Telbivudine—hepatitis B	0.00125	0.00142	CcSEcCtD
Citalopram—Immune system disorder—Lamivudine—hepatitis B	0.00125	0.00141	CcSEcCtD
Citalopram—Mediastinal disorder—Lamivudine—hepatitis B	0.00124	0.00141	CcSEcCtD
Citalopram—Chills—Lamivudine—hepatitis B	0.00124	0.0014	CcSEcCtD
Citalopram—CYP3A4—blood plasma—hepatitis B	0.00123	0.0566	CbGeAlD
Citalopram—Pruritus—Telbivudine—hepatitis B	0.00123	0.0014	CcSEcCtD
Citalopram—Nausea—Adefovir Dipivoxil—hepatitis B	0.00123	0.00139	CcSEcCtD
Citalopram—Alopecia—Lamivudine—hepatitis B	0.00122	0.00138	CcSEcCtD
Citalopram—CYP2D6—blood plasma—hepatitis B	0.00121	0.0557	CbGeAlD
Citalopram—Erythema—Lamivudine—hepatitis B	0.0012	0.00136	CcSEcCtD
Citalopram—Malnutrition—Lamivudine—hepatitis B	0.0012	0.00136	CcSEcCtD
Citalopram—Diarrhoea—Telbivudine—hepatitis B	0.00119	0.00135	CcSEcCtD
Citalopram—Flatulence—Lamivudine—hepatitis B	0.00118	0.00134	CcSEcCtD
Citalopram—Tension—Lamivudine—hepatitis B	0.00118	0.00134	CcSEcCtD
Citalopram—Dysgeusia—Lamivudine—hepatitis B	0.00118	0.00133	CcSEcCtD
Citalopram—Nervousness—Lamivudine—hepatitis B	0.00117	0.00132	CcSEcCtD
Citalopram—Back pain—Lamivudine—hepatitis B	0.00116	0.00132	CcSEcCtD
Citalopram—Muscle spasms—Lamivudine—hepatitis B	0.00115	0.00131	CcSEcCtD
Citalopram—Dizziness—Telbivudine—hepatitis B	0.00115	0.0013	CcSEcCtD
Citalopram—Tremor—Lamivudine—hepatitis B	0.00112	0.00128	CcSEcCtD
Citalopram—Ill-defined disorder—Lamivudine—hepatitis B	0.00111	0.00126	CcSEcCtD
Citalopram—Anaemia—Lamivudine—hepatitis B	0.00111	0.00126	CcSEcCtD
Citalopram—Vomiting—Telbivudine—hepatitis B	0.0011	0.00125	CcSEcCtD
Citalopram—Angioedema—Lamivudine—hepatitis B	0.0011	0.00124	CcSEcCtD
Citalopram—Rash—Telbivudine—hepatitis B	0.0011	0.00124	CcSEcCtD
Citalopram—Dermatitis—Telbivudine—hepatitis B	0.00109	0.00124	CcSEcCtD
Citalopram—Headache—Telbivudine—hepatitis B	0.00109	0.00124	CcSEcCtD
Citalopram—Malaise—Lamivudine—hepatitis B	0.00108	0.00123	CcSEcCtD
Citalopram—Vertigo—Lamivudine—hepatitis B	0.00108	0.00122	CcSEcCtD
Citalopram—Syncope—Lamivudine—hepatitis B	0.00108	0.00122	CcSEcCtD
Citalopram—Leukopenia—Lamivudine—hepatitis B	0.00107	0.00122	CcSEcCtD
Citalopram—Loss of consciousness—Lamivudine—hepatitis B	0.00105	0.0012	CcSEcCtD
Citalopram—Cough—Lamivudine—hepatitis B	0.00105	0.00119	CcSEcCtD
Citalopram—Convulsion—Lamivudine—hepatitis B	0.00104	0.00118	CcSEcCtD
Citalopram—Nausea—Telbivudine—hepatitis B	0.00103	0.00117	CcSEcCtD
Citalopram—Arthralgia—Lamivudine—hepatitis B	0.00102	0.00116	CcSEcCtD
Citalopram—Chest pain—Lamivudine—hepatitis B	0.00102	0.00116	CcSEcCtD
Citalopram—Myalgia—Lamivudine—hepatitis B	0.00102	0.00116	CcSEcCtD
Citalopram—Anxiety—Lamivudine—hepatitis B	0.00102	0.00116	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00101	0.00115	CcSEcCtD
Citalopram—Discomfort—Lamivudine—hepatitis B	0.00101	0.00115	CcSEcCtD
Citalopram—Dry mouth—Lamivudine—hepatitis B	0.000999	0.00113	CcSEcCtD
Citalopram—Confusional state—Lamivudine—hepatitis B	0.000988	0.00112	CcSEcCtD
Citalopram—Oedema—Lamivudine—hepatitis B	0.000979	0.00111	CcSEcCtD
Citalopram—Anaphylactic shock—Lamivudine—hepatitis B	0.000979	0.00111	CcSEcCtD
Citalopram—Infection—Lamivudine—hepatitis B	0.000973	0.0011	CcSEcCtD
Citalopram—Shock—Lamivudine—hepatitis B	0.000964	0.00109	CcSEcCtD
Citalopram—Nervous system disorder—Lamivudine—hepatitis B	0.00096	0.00109	CcSEcCtD
Citalopram—Thrombocytopenia—Lamivudine—hepatitis B	0.000959	0.00109	CcSEcCtD
Citalopram—Skin disorder—Lamivudine—hepatitis B	0.000951	0.00108	CcSEcCtD
Citalopram—Hyperhidrosis—Lamivudine—hepatitis B	0.000947	0.00107	CcSEcCtD
Citalopram—Anorexia—Lamivudine—hepatitis B	0.000934	0.00106	CcSEcCtD
Citalopram—SLC6A4—blood—hepatitis B	0.000923	0.0424	CbGeAlD
Citalopram—Hypotension—Lamivudine—hepatitis B	0.000915	0.00104	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000892	0.00101	CcSEcCtD
Citalopram—Insomnia—Lamivudine—hepatitis B	0.000886	0.00101	CcSEcCtD
Citalopram—Paraesthesia—Lamivudine—hepatitis B	0.000879	0.000999	CcSEcCtD
Citalopram—ABCB1—blood plasma—hepatitis B	0.000874	0.0401	CbGeAlD
Citalopram—Dyspnoea—Lamivudine—hepatitis B	0.000873	0.000991	CcSEcCtD
Citalopram—Somnolence—Lamivudine—hepatitis B	0.000871	0.000989	CcSEcCtD
Citalopram—Dyspepsia—Lamivudine—hepatitis B	0.000862	0.000979	CcSEcCtD
Citalopram—Decreased appetite—Lamivudine—hepatitis B	0.000851	0.000967	CcSEcCtD
Citalopram—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000846	0.00096	CcSEcCtD
Citalopram—Fatigue—Lamivudine—hepatitis B	0.000844	0.000959	CcSEcCtD
Citalopram—Constipation—Lamivudine—hepatitis B	0.000838	0.000951	CcSEcCtD
Citalopram—Pain—Lamivudine—hepatitis B	0.000838	0.000951	CcSEcCtD
Citalopram—Feeling abnormal—Lamivudine—hepatitis B	0.000807	0.000916	CcSEcCtD
Citalopram—Gastrointestinal pain—Lamivudine—hepatitis B	0.000801	0.000909	CcSEcCtD
Citalopram—Urticaria—Lamivudine—hepatitis B	0.000778	0.000883	CcSEcCtD
Citalopram—Body temperature increased—Lamivudine—hepatitis B	0.000774	0.000879	CcSEcCtD
Citalopram—Abdominal pain—Lamivudine—hepatitis B	0.000774	0.000879	CcSEcCtD
Citalopram—CYP2C19—blood—hepatitis B	0.000765	0.0351	CbGeAlD
Citalopram—ADRA1A—blood—hepatitis B	0.000756	0.0347	CbGeAlD
Citalopram—Hypersensitivity—Lamivudine—hepatitis B	0.000722	0.000819	CcSEcCtD
Citalopram—Asthenia—Lamivudine—hepatitis B	0.000703	0.000798	CcSEcCtD
Citalopram—Pruritus—Lamivudine—hepatitis B	0.000693	0.000787	CcSEcCtD
Citalopram—Diarrhoea—Lamivudine—hepatitis B	0.00067	0.000761	CcSEcCtD
Citalopram—Dizziness—Lamivudine—hepatitis B	0.000648	0.000735	CcSEcCtD
Citalopram—CYP1A2—blood—hepatitis B	0.000625	0.0287	CbGeAlD
Citalopram—Vomiting—Lamivudine—hepatitis B	0.000623	0.000707	CcSEcCtD
Citalopram—Rash—Lamivudine—hepatitis B	0.000618	0.000701	CcSEcCtD
Citalopram—Dermatitis—Lamivudine—hepatitis B	0.000617	0.0007	CcSEcCtD
Citalopram—Headache—Lamivudine—hepatitis B	0.000614	0.000697	CcSEcCtD
Citalopram—CYP2B6—blood—hepatitis B	0.000599	0.0275	CbGeAlD
Citalopram—CYP2C19—liver—hepatitis B	0.000598	0.0275	CbGeAlD
Citalopram—ADRA1A—liver—hepatitis B	0.000591	0.0271	CbGeAlD
Citalopram—Nausea—Lamivudine—hepatitis B	0.000582	0.000661	CcSEcCtD
Citalopram—CYP2E1—blood—hepatitis B	0.000562	0.0258	CbGeAlD
Citalopram—CYP1A2—liver—hepatitis B	0.000489	0.0224	CbGeAlD
Citalopram—CYP2B6—liver—hepatitis B	0.000468	0.0215	CbGeAlD
Citalopram—CYP3A4—blood—hepatitis B	0.000452	0.0208	CbGeAlD
Citalopram—CYP2D6—blood—hepatitis B	0.000445	0.0204	CbGeAlD
Citalopram—CYP2E1—liver—hepatitis B	0.00044	0.0202	CbGeAlD
Citalopram—CYP3A4—liver—hepatitis B	0.000354	0.0162	CbGeAlD
Citalopram—CYP2D6—liver—hepatitis B	0.000348	0.016	CbGeAlD
Citalopram—ABCB1—blood—hepatitis B	0.00032	0.0147	CbGeAlD
Citalopram—ABCB1—liver—hepatitis B	0.00025	0.0115	CbGeAlD
Citalopram—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000233	0.00239	CbGpPWpGaD
Citalopram—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.00023	0.00236	CbGpPWpGaD
Citalopram—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.00023	0.00236	CbGpPWpGaD
Citalopram—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000228	0.00234	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—CDKN1A—hepatitis B	0.000226	0.00232	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000226	0.00231	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000224	0.0023	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000215	0.00221	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000213	0.00218	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000208	0.00213	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000204	0.0021	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000198	0.00203	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—F2—hepatitis B	0.000195	0.002	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000191	0.00196	CbGpPWpGaD
Citalopram—HTR2C—G alpha (q) signalling events—F2—hepatitis B	0.000189	0.00193	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000188	0.00193	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—FAS—hepatitis B	0.000178	0.00182	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000176	0.00181	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000176	0.0018	CbGpPWpGaD
Citalopram—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	0.000174	0.00179	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00017	0.00174	CbGpPWpGaD
Citalopram—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.00017	0.00174	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000169	0.00173	CbGpPWpGaD
Citalopram—HRH1—G alpha (q) signalling events—F2—hepatitis B	0.000163	0.00168	CbGpPWpGaD
Citalopram—CHRM1—G alpha (q) signalling events—F2—hepatitis B	0.000163	0.00167	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	0.000163	0.00167	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000163	0.00167	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000162	0.00166	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000162	0.00166	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00016	0.00165	CbGpPWpGaD
Citalopram—ADRA1A—G alpha (q) signalling events—F2—hepatitis B	0.00016	0.00164	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00016	0.00164	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000159	0.00163	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000156	0.0016	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000154	0.00158	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—TP53—hepatitis B	0.000154	0.00158	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—NOS2—hepatitis B	0.000152	0.00156	CbGpPWpGaD
Citalopram—SLC6A2—NRF2 pathway—TGFB1—hepatitis B	0.00015	0.00154	CbGpPWpGaD
Citalopram—SLC6A2—SLC-mediated transmembrane transport—ALB—hepatitis B	0.000149	0.00153	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000149	0.00153	CbGpPWpGaD
Citalopram—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000147	0.00151	CbGpPWpGaD
Citalopram—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000147	0.00151	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000146	0.0015	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000146	0.00149	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000146	0.00149	CbGpPWpGaD
Citalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000144	0.00148	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000143	0.00147	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCL10—hepatitis B	0.000143	0.00147	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000138	0.00142	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000137	0.00141	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000136	0.00139	CbGpPWpGaD
Citalopram—SLC6A3—NRF2 pathway—TGFB1—hepatitis B	0.000133	0.00136	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000133	0.00136	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—ALB—hepatitis B	0.000132	0.00136	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000126	0.00129	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000126	0.00129	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000125	0.00128	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000124	0.00128	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000124	0.00127	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000124	0.00127	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL10—hepatitis B	0.000124	0.00127	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000124	0.00127	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL10—hepatitis B	0.000123	0.00127	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL10—hepatitis B	0.000122	0.00125	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000121	0.00124	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000117	0.0012	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000116	0.00119	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	0.000111	0.00114	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CCR5—hepatitis B	0.000111	0.00114	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SAG—hepatitis B	0.00011	0.00113	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RIT2—hepatitis B	0.00011	0.00113	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000108	0.00111	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000108	0.00111	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000108	0.00111	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000106	0.00109	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000106	0.00109	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	0.000102	0.00104	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000101	0.00103	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—PTEN—hepatitis B	9.74e-05	0.000999	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CCR5—hepatitis B	9.6e-05	0.000985	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CCR5—hepatitis B	9.57e-05	0.000982	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SAG—hepatitis B	9.51e-05	0.000976	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RIT2—hepatitis B	9.51e-05	0.000976	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—F2—hepatitis B	9.51e-05	0.000975	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SAG—hepatitis B	9.48e-05	0.000972	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RIT2—hepatitis B	9.48e-05	0.000972	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CCR5—hepatitis B	9.42e-05	0.000967	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RIT2—hepatitis B	9.33e-05	0.000957	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SAG—hepatitis B	9.33e-05	0.000957	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKR1B1—hepatitis B	8.79e-05	0.000902	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKR1B1—hepatitis B	8.61e-05	0.000883	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GGT2—hepatitis B	8.43e-05	0.000865	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GGT2—hepatitis B	8.26e-05	0.000847	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—F2—hepatitis B	8.24e-05	0.000845	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—F2—hepatitis B	8.21e-05	0.000843	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—F2—hepatitis B	8.08e-05	0.000829	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL10—hepatitis B	8.08e-05	0.000828	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	7.58e-05	0.000778	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL10—hepatitis B	7.33e-05	0.000752	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL10—hepatitis B	7e-05	0.000718	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL10—hepatitis B	6.98e-05	0.000716	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL10—hepatitis B	6.87e-05	0.000704	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.76e-05	0.000694	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	6.72e-05	0.000689	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	6.67e-05	0.000685	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—hepatitis B	6.65e-05	0.000682	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKR1B1—hepatitis B	6.64e-05	0.000682	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	6.58e-05	0.000675	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKR1B1—hepatitis B	6.48e-05	0.000665	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	6.43e-05	0.00066	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	6.42e-05	0.000658	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	6.39e-05	0.000655	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GGT2—hepatitis B	6.37e-05	0.000653	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL10—hepatitis B	6.35e-05	0.000652	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL10—hepatitis B	6.33e-05	0.00065	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCR5—hepatitis B	6.26e-05	0.000643	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL10—hepatitis B	6.24e-05	0.00064	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GGT2—hepatitis B	6.22e-05	0.000638	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKR1B1—hepatitis B	6.11e-05	0.000627	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—hepatitis B	6.08e-05	0.000624	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GGT2—hepatitis B	5.86e-05	0.000601	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	5.78e-05	0.000593	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	5.77e-05	0.000591	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCR5—hepatitis B	5.69e-05	0.000583	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	5.68e-05	0.000582	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCR5—hepatitis B	5.43e-05	0.000557	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCR5—hepatitis B	5.41e-05	0.000555	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—F2—hepatitis B	5.37e-05	0.000551	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCR5—hepatitis B	5.33e-05	0.000546	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.32e-05	0.000546	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.27e-05	0.000541	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKR1B1—hepatitis B	5.18e-05	0.000531	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CYP2A6—hepatitis B	5.11e-05	0.000524	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CYP2A6—hepatitis B	5e-05	0.000513	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	4.97e-05	0.00051	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GGT2—hepatitis B	4.96e-05	0.000509	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCR5—hepatitis B	4.93e-05	0.000506	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR5—hepatitis B	4.91e-05	0.000504	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—F2—hepatitis B	4.88e-05	0.000501	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR5—hepatitis B	4.84e-05	0.000496	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—F2—hepatitis B	4.66e-05	0.000478	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—F2—hepatitis B	4.64e-05	0.000476	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GOT2—hepatitis B	4.62e-05	0.000474	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—F2—hepatitis B	4.57e-05	0.000469	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GOT2—hepatitis B	4.52e-05	0.000464	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.38e-05	0.000449	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL10—hepatitis B	4.33e-05	0.000444	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—F2—hepatitis B	4.23e-05	0.000434	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—F2—hepatitis B	4.21e-05	0.000432	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—F2—hepatitis B	4.15e-05	0.000426	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKR1B1—hepatitis B	4e-05	0.00041	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GGT1—hepatitis B	3.99e-05	0.000409	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GOT1—hepatitis B	3.99e-05	0.000409	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GGT1—hepatitis B	3.9e-05	0.000401	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GOT1—hepatitis B	3.9e-05	0.000401	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CYP2A6—hepatitis B	3.86e-05	0.000396	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GGT2—hepatitis B	3.83e-05	0.000393	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CYP2A6—hepatitis B	3.77e-05	0.000386	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL10—hepatitis B	3.75e-05	0.000385	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL10—hepatitis B	3.74e-05	0.000384	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL10—hepatitis B	3.68e-05	0.000378	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2—hepatitis B	3.62e-05	0.000371	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.6e-05	0.000369	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CYP2A6—hepatitis B	3.55e-05	0.000364	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GOT2—hepatitis B	3.49e-05	0.000358	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GOT2—hepatitis B	3.41e-05	0.000349	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR5—hepatitis B	3.36e-05	0.000345	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	3.34e-05	0.000343	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2—hepatitis B	3.29e-05	0.000337	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GOT2—hepatitis B	3.21e-05	0.000329	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2—hepatitis B	3.14e-05	0.000322	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2—hepatitis B	3.13e-05	0.000321	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2—hepatitis B	3.08e-05	0.000316	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GOT1—hepatitis B	3.01e-05	0.000309	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GGT1—hepatitis B	3.01e-05	0.000309	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CYP2A6—hepatitis B	3.01e-05	0.000308	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GGT1—hepatitis B	2.94e-05	0.000302	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GOT1—hepatitis B	2.94e-05	0.000302	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR5—hepatitis B	2.91e-05	0.000299	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR5—hepatitis B	2.9e-05	0.000298	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—F2—hepatitis B	2.88e-05	0.000296	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR5—hepatitis B	2.86e-05	0.000293	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2—hepatitis B	2.85e-05	0.000292	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2—hepatitis B	2.84e-05	0.000291	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.8e-05	0.000288	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2—hepatitis B	2.79e-05	0.000287	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GGT1—hepatitis B	2.77e-05	0.000284	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GOT1—hepatitis B	2.77e-05	0.000284	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.75e-05	0.000282	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GOT2—hepatitis B	2.72e-05	0.000279	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—F2—hepatitis B	2.5e-05	0.000256	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—F2—hepatitis B	2.49e-05	0.000255	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—F2—hepatitis B	2.45e-05	0.000251	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GGT1—hepatitis B	2.35e-05	0.000241	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GOT1—hepatitis B	2.35e-05	0.000241	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.32e-05	0.000238	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.14e-05	0.000219	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—hepatitis B	2.12e-05	0.000218	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT2—hepatitis B	2.1e-05	0.000215	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—hepatitis B	2.08e-05	0.000213	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2—hepatitis B	1.94e-05	0.000199	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—hepatitis B	1.93e-05	0.000198	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	1.87e-05	0.000192	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	1.83e-05	0.000188	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTEN—hepatitis B	1.83e-05	0.000187	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NFKB1—hepatitis B	1.82e-05	0.000186	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GGT1—hepatitis B	1.81e-05	0.000186	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GOT1—hepatitis B	1.81e-05	0.000186	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2—hepatitis B	1.68e-05	0.000173	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2—hepatitis B	1.68e-05	0.000172	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—hepatitis B	1.67e-05	0.000172	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—hepatitis B	1.67e-05	0.000171	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2—hepatitis B	1.65e-05	0.000169	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—hepatitis B	1.64e-05	0.000168	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CTNNB1—hepatitis B	1.62e-05	0.000167	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CTNNB1—hepatitis B	1.62e-05	0.000166	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTEN—hepatitis B	1.62e-05	0.000166	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—hepatitis B	1.6e-05	0.000164	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	1.59e-05	0.000163	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDKN1A—hepatitis B	1.59e-05	0.000163	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTEN—hepatitis B	1.58e-05	0.000163	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTEN—hepatitis B	1.58e-05	0.000162	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDKN1A—hepatitis B	1.58e-05	0.000162	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTEN—hepatitis B	1.58e-05	0.000162	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NFKB1—hepatitis B	1.58e-05	0.000162	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NFKB1—hepatitis B	1.57e-05	0.000161	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—hepatitis B	1.56e-05	0.00016	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	1.56e-05	0.00016	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTEN—hepatitis B	1.55e-05	0.000159	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	1.55e-05	0.000159	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TGFB1—hepatitis B	1.51e-05	0.000155	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—hepatitis B	1.47e-05	0.000151	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TGFB1—hepatitis B	1.31e-05	0.000135	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TGFB1—hepatitis B	1.31e-05	0.000134	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	1.29e-05	0.000132	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—hepatitis B	1.25e-05	0.000128	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—hepatitis B	1.25e-05	0.000128	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTEN—hepatitis B	1.22e-05	0.000125	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTEN—hepatitis B	1.19e-05	0.000122	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—hepatitis B	1.14e-05	0.000117	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTEN—hepatitis B	1.12e-05	0.000115	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—hepatitis B	1.08e-05	0.000111	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—hepatitis B	1.08e-05	0.00011	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—hepatitis B	1.06e-05	0.000109	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—hepatitis B	9.89e-06	0.000101	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—hepatitis B	9.86e-06	0.000101	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—hepatitis B	9.7e-06	9.95e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—hepatitis B	9.64e-06	9.89e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTEN—hepatitis B	9.53e-06	9.77e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTEN—hepatitis B	7.35e-06	7.54e-05	CbGpPWpGaD
